Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. ENRC.L Share Price
  4. ENRC.L Share Regulatory News
  5. Form 8.5 (EPT/NON-RI) - ENRC

Pin to quick picksENRC.L Regulatory News (ENRC)

ENRC.L Information
  • There is currently no data for ENRC

Form 8.5 (EPT/NON-RI) - ENRC

6 Jun 2013 10:25

RNS Number : 4539G
Societe Generale SA
06 June 2013
 



FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

SOCIETE GENERALE SA

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Eurasian Natural Resources Corp Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Mr. Alexander Machkevitch, Mr. Alijan Ibragimov, Mr. Patokh Chodiev and the Kazakh Government

(d) Date position held/dealing undertaken:

05/06/2013

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES: Kazakhmys Plc

 

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

USD 0.20 Ordinary share

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

595,068

0.05

73,800

0.01

(2) Derivatives (other than options):

0

0.00

2,000

0.00

(3) Options and agreements to purchase/sell:

0

 

0.00

0

 

0.00

TOTAL:

595,068

0.05

75,800

0.01

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

(GBP)

Ordinary share

Purchase

3,701

2.4380

Ordinary share

Purchase

973

2.4350

Ordinary share

Purchase

1,893

2.4550

Ordinary share

Purchase

3,587

2.4270

Ordinary share

Purchase

213

2.4430

Ordinary share

Purchase

2,593

2.4600

Ordinary share

Purchase

1,780

2.4430

Ordinary share

Purchase

575

2.4530

Ordinary share

Purchase

192

2.4240

Ordinary share

Purchase

524

2.4630

Ordinary share

Purchase

1,664

2.4380

Ordinary share

Purchase

1,829

2.4720

Ordinary share

Purchase

2,466

2.4380

Ordinary share

Purchase

3,652

2.4430

Ordinary share

Purchase

2,676

2.4440

Ordinary share

Purchase

450

2.4380

Ordinary share

Purchase

767

2.4430

Ordinary share

Purchase

278

2.4320

Ordinary share

Purchase

2,665

2.4260

Ordinary share

Purchase

363

2.4770

Ordinary share

Purchase

821

2.4600

Ordinary share

Purchase

1,353

2.4440

Ordinary share

Purchase

14,406

2.4290

Ordinary share

Purchase

2,499

2.4120

Ordinary share

Purchase

2,520

2.4270

Ordinary share

Purchase

2,373

2.4430

Ordinary share

Purchase

86

2.4550

Ordinary share

Purchase

2,501

2.4270

Ordinary share

Purchase

113

2.4340

Ordinary share

Purchase

1,878

2.4340

Ordinary share

Purchase

529

2.4720

Ordinary share

Purchase

622

2.4240

Ordinary share

Purchase

664

2.4760

Ordinary share

Purchase

192

2.4240

Ordinary share

Purchase

1,027

2.4120

Ordinary share

Purchase

2,530

2.4120

Ordinary share

Purchase

658

2.4720

Ordinary share

Purchase

1,154

2.4240

Ordinary share

Purchase

512

2.4320

Ordinary share

Purchase

649

2.4320

Ordinary share

Purchase

938

2.4320

Ordinary share

Purchase

2,584

2.4260

Ordinary share

Purchase

834

2.4380

Ordinary share

Purchase

666

2.4530

Ordinary share

Purchase

11,227

2.4270

Ordinary share

Purchase

2,654

2.4310

Ordinary share

Purchase

480

2.4220

Ordinary share

Purchase

1,003

2.4340

Ordinary share

Purchase

2,871

2.4600

Ordinary share

Purchase

1,931

2.4700

Ordinary share

Purchase

1,157

2.4420

Ordinary share

Purchase

137

2.4770

Ordinary share

Purchase

3,730

2.4260

Ordinary share

Purchase

353

2.4600

Ordinary share

Purchase

1,766

2.4350

Ordinary share

Purchase

2,645

2.4310

Ordinary share

Purchase

3,688

2.4310

Ordinary share

Purchase

192

2.4240

Ordinary share

Purchase

505

2.4240

Ordinary share

Purchase

3,107

2.4350

Ordinary share

Purchase

1,822

2.4320

Ordinary share

Purchase

389

2.4410

Ordinary share

Purchase

822

2.4550

Ordinary share

Purchase

1,438

2.4350

Ordinary share

Purchase

418

2.4190

Ordinary share

Purchase

2,620

2.4120

Ordinary share

Purchase

2,515

2.4430

Ordinary share

Purchase

2,547

2.4600

Ordinary share

Purchase

2,514

2.4260

Ordinary share

Purchase

2,499

2.4270

Ordinary share

Purchase

504

2.4310

Ordinary share

Purchase

663

2.4630

Ordinary share

Purchase

882

2.4580

Ordinary share

Purchase

190

2.4410

Ordinary share

Purchase

2,642

2.4600

Ordinary share

Purchase

2,204

2.4310

Ordinary share

Purchase

1,603

2.4120

Ordinary share

Sale

197

2.4240

Ordinary share

Sale

1,396

2.4380

Ordinary share

Sale

934

2.4350

Ordinary share

Sale

1,123

2.4380

Ordinary share

Sale

1,865

2.4420

Ordinary share

Sale

2,547

2.4380

Ordinary share

Sale

59

2.4450

Ordinary share

Sale

818

2.4520

Ordinary share

Sale

1,739

2.4380

Ordinary share

Sale

32

2.4510

Ordinary share

Sale

221

2.4520

Ordinary share

Sale

320

2.4370

Ordinary share

Sale

539

2.4560

Ordinary share

Sale

1,018

2.4350

Ordinary share

Sale

2,620

2.4500

Ordinary share

Sale

2,534

2.4430

Ordinary share

Sale

1,835

2.4350

Ordinary share

Sale

1,739

2.4170

Ordinary share

Sale

2,606

2.4430

Ordinary share

Sale

828

2.4700

Ordinary share

Sale

400

2.4340

Ordinary share

Sale

83

2.4500

Ordinary share

Sale

1,392

2.4380

Ordinary share

Sale

1,739

2.4350

Ordinary share

Sale

194

2.4260

Ordinary share

Sale

2,595

2.4260

Ordinary share

Sale

107

2.4370

Ordinary share

Sale

766

2.4670

Ordinary share

Sale

459

2.4770

Ordinary share

Sale

116

2.4270

Ordinary share

Sale

2,499

2.4500

Ordinary share

Sale

2,514

2.4390

Ordinary share

Sale

2,527

2.4460

Ordinary share

Sale

2,595

2.4640

Ordinary share

Sale

708

2.4550

Ordinary share

Sale

725

2.4750

Ordinary share

Sale

921

2.4520

Ordinary share

Sale

1

2.4490

Ordinary share

Sale

699

2.4770

Ordinary share

Sale

2,177

2.4370

Ordinary share

Sale

300

2.4220

Ordinary share

Sale

2,467

2.4390

Ordinary share

Sale

59

2.4400

Ordinary share

Sale

2,200

2.4390

Ordinary share

Sale

2,632

2.4640

Ordinary share

Sale

395

2.4370

Ordinary share

Sale

1,331

2.4300

Ordinary share

Sale

325

2.4390

Ordinary share

Sale

1,932

2.4330

Ordinary share

Sale

433

2.4330

Ordinary share

Sale

2,630

2.4500

Ordinary share

Sale

3

2.4330

Ordinary share

Sale

4

2.4380

Ordinary share

Sale

444

2.4330

Ordinary share

Sale

803

2.4270

Ordinary share

Sale

1,060

2.4340

Ordinary share

Sale

576

2.4750

Ordinary share

Sale

708

2.4800

Ordinary share

Sale

81

2.4560

Ordinary share

Sale

242

2.4350

Ordinary share

Sale

561

2.4390

Ordinary share

Sale

1,933

2.4260

Ordinary share

Sale

59

2.4340

Ordinary share

Sale

59

2.4330

Ordinary share

Sale

2,557

2.4330

Ordinary share

Sale

432

2.4500

Ordinary share

Sale

1,878

2.4410

Ordinary share

Sale

332

2.4390

Ordinary share

Sale

2,512

2.4260

Ordinary share

Sale

1,414

2.4390

Ordinary share

Sale

79

2.4500

Ordinary share

Sale

1,745

2.4510

Ordinary share

Sale

2,300

2.4270

Ordinary share

Sale

579

2.4700

Ordinary share

Sale

1,739

2.4550

Ordinary share

Sale

101

2.4350

Ordinary share

Sale

504

2.4220

Ordinary share

Sale

111

2.4530

Ordinary share

Sale

10

2.4380

Ordinary share

Sale

1,257

2.4530

Ordinary share

Sale

227

2.4520

Ordinary share

Sale

342

2.4490

Ordinary share

Sale

593

2.4320

Ordinary share

Sale

1,739

2.4340

Ordinary share

Sale

68

2.4420

Ordinary share

Sale

83

2.4320

Ordinary share

Sale

759

2.4490

Ordinary share

Sale

507

2.4510

Ordinary share

Sale

903

2.4300

Ordinary share

Sale

1,032

2.4350

Ordinary share

Sale

367

2.4370

Ordinary share

Sale

2,622

2.4640

Ordinary share

Sale

1,741

2.4390

Ordinary share

Sale

960

2.4270

Ordinary share

Sale

59

2.4400

Ordinary share

Sale

410

2.4260

Ordinary share

Sale

730

2.4420

Ordinary share

Sale

778

2.4550

Ordinary share

Sale

48

2.4340

Ordinary share

Sale

2,507

2.4390

Ordinary share

Sale

400

2.4220

Ordinary share

Sale

286

2.4510

Ordinary share

Sale

498

2.4500

Ordinary share

Sale

708

2.4680

Ordinary share

Sale

262

2.4380

Ordinary share

Sale

277

2.4390

Ordinary share

Sale

1,150

2.4750

Ordinary share

Sale

2,559

2.4430

Ordinary share

Sale

59

2.4350

Ordinary share

Sale

714

2.4750

Ordinary share

Sale

808

2.4800

Ordinary share

Sale

1,000

2.4360

Ordinary share

Sale

5

2.4380

Ordinary share

Sale

2,700

2.4430

Ordinary share

Sale

822

2.4690

Ordinary share

Sale

2,628

2.4640

Ordinary share

Sale

1,155

2.4380

Ordinary share

Sale

660

2.4810

Ordinary share

Sale

2,560

2.4460

Ordinary share

Sale

1,431

2.4380

Ordinary share

Sale

1,739

2.4380

Ordinary share

Sale

737

2.4670

Ordinary share

Sale

512

2.4350

Ordinary share

Sale

75

2.4500

Ordinary share

Sale

1,861

2.4220

Ordinary share

Sale

11

2.4240

Ordinary share

Sale

970

2.4490

Ordinary share

Sale

56

2.4290

Ordinary share

Sale

637

2.4530

Ordinary share

Sale

2,654

2.4460

Ordinary share

Sale

750

2.4750

Ordinary share

Sale

58

2.4770

Ordinary share

Sale

2,009

2.4220

Ordinary share

Sale

2,543

2.4420

Ordinary share

Sale

1,739

2.4350

Ordinary share

Sale

771

2.4750

Ordinary share

Sale

408

2.4300

Ordinary share

Sale

574

2.4390

Ordinary share

Sale

2,497

2.4220

Ordinary share

Sale

1,600

2.4500

Ordinary share

Sale

126

2.4490

Ordinary share

Sale

44

2.4340

Ordinary share

Sale

126

2.4320

Ordinary share

Sale

1,636

2.4220

Ordinary share

Sale

1,074

2.4370

Ordinary share

Sale

886

2.4300

Ordinary share

Sale

813

2.4750

Ordinary share

Sale

459

2.4220

Ordinary share

Sale

691

2.4680

Ordinary share

Sale

1,377

2.4320

Ordinary share

Sale

1,161

2.4380

Ordinary share

Sale

677

2.4560

Ordinary share

Sale

1,037

2.4660

Ordinary share

Sale

364

2.4490

Ordinary share

Sale

75

2.4390

Ordinary share

Sale

2,590

2.4460

Ordinary share

Sale

1,616

2.4300

Ordinary share

Sale

960

2.4270

Ordinary share

Sale

362

2.4340

Total purchases

138,668

Total sales

162,406

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit (GBP)

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

06/06/2013

Contact name:

Benoît Champion

Telephone number:

+44 20 7676 6280

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOZMGGVLVFGFZG
151617181920212223
Date   Source Headline
22nd Apr 20139:30 amRNSForm 8.5 (EPT/RI) ENRC PLC
22nd Apr 20139:29 amRNSForm 8.5 (EPT/RI) ENRC PLC
19th Apr 20134:33 pmRNSResponse to Announcement
19th Apr 20131:50 pmRNSrecent press speculation
11th Apr 20133:30 pmRNSDirectorate Change
20th Mar 20137:00 amRNSFinal Results
27th Feb 201311:30 amRNSUpdate on Effective Tax Rate and Annual Impairment
6th Feb 20137:00 amRNSQ4 Production Report
28th Dec 20124:15 pmRNSCompletion of Acquisition
28th Dec 201211:00 amRNSResult of EGM
10th Dec 20124:21 pmRNSCirc re. Camrose acquisition
10th Dec 20127:00 amRNSAcquisition
23rd Nov 20127:00 amRNSBoard and Senior Management Changes
8th Nov 20127:00 amRNSQ3 Production Report and IMS
1st Oct 201211:06 amRNSPostponement of Proposed Copper Seminar
15th Aug 20127:00 amRNSHalf Yearly Report
10th Aug 20124:15 pmRNSChanges to Board Committees
1st Aug 20127:00 amRNSQ2 Production Report
31st Jul 20127:00 amRNSAcquisition of Frontier Licence
12th Jun 20123:15 pmRNSResult of AGM
29th May 20124:40 pmRNS2011 Sustainable Development Report
25th May 201212:36 pmRNSDirectorate Change
11th May 20125:39 pmRNSAnnual Information Update
10th May 20127:00 amRNSInterim Management Statement
8th May 20127:00 amRNSStatement re Press Speculation
4th May 20127:00 amRNSDirector/PDMR Shareholding
4th May 20127:00 amRNSDirector/PDMR Shareholding
4th May 20127:00 amRNSDirector/PDMR Shareholding
26th Apr 20125:12 pmRNSAnnual Financial Report
17th Apr 20127:00 amRNSCompletion of Shubarkol Acquisition
2nd Apr 20121:23 pmRNSResult of EGM
21st Mar 20126:04 pmRNSCirc re. reconvening of General Meeting
21st Mar 20127:00 amRNSFinal Results
21st Mar 20127:00 amRNSReconvening of General Meeting
2nd Mar 20121:30 pmRNSCompletion of Acquisition
2nd Mar 20121:30 pmRNSClosure of Previously Announced Transaction
28th Feb 201212:30 pmRNSLoan Facility
21st Feb 20122:45 pmRNSMMK Contract Update
3rd Feb 20122:33 pmRNSBoard Changes
1st Feb 20127:00 amRNSQ4 Production Report
5th Jan 201212:34 pmRNSFIRST QUANTUM REACHES AGREEMENT WITH ENRC
5th Jan 201212:28 pmRNSConference Call re Acquisition
5th Jan 201212:27 pmRNSAcquisition and Legal Settlement
14th Dec 20115:13 pmRNSDirector Declaration
5th Dec 20111:01 pmRNSENRC and MMK settled legal claims
10th Nov 20117:00 amRNSQ3 Production Report and IMS
7th Nov 20114:18 pmRNSResult of EGM
4th Nov 20113:30 pmRNSAdjournment of General Meeting
11th Oct 20115:30 pmRNSCirc re. Proposed Exercise of Option
11th Oct 201112:30 pmRNSSite Visits for Analysts
151617181920212223

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
GSK
Glaxosmithkline
LSE
-1.01%
MAB
Mitchells & Butlers
LSE
-0.57%
VEC
VEC.L
LSE
0.00%
LWB
LWB.L
LSE
0.00%
DSCV
DiscoverIE
LSE
2.99%
Trending
CPI
Capita
LSE
-20.65%
MTL
Metals Exploration
LSE
1.17%
GST
GSTechnologies
LSE
-10.00%
AVCT
Avacta Group
LSE
1.44%
PRD
Predator Oil
LSE
0.00%